After treatment with semaglutide, newly diagnosed type 1 diabetes patients found to need little or no insulin

Treating newly diagnosed type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

Leave A Comment

Your email address will not be published. Required fields are marked *